Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XNW5004 Combined With CHOP/CHOEP in Untreated Peripheral T-Cell Lymphoma
NCT07730515Phase 2Recruiting
- Sponsor
- Evopoint Biosciences
- Start
- Aug 2025
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of igermetostat in peripheral T-cell lymphoma (PTCL), sponsored by Evopoint Biosciences. Started Aug 2025; status: recruiting.
02
Drugs
igermetostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT07730515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07730515.